![]() | This lead contains content that is written like
an advertisement. (August 2021) |
![]() | |
Formerly | Indegene Lifesystems Private Limited (1998–2016) Indegene Private Limited (2016–2022) |
---|---|
Company type | Public |
Industry | |
Founded | 1998 |
Founders | Rajesh Nair Manish Gupta Sanjay Parikh Anand Kiran Gaurav Kapoor |
Headquarters | , India |
Area served | Worldwide |
Key people | Manish Gupta (CEO) [1] |
Revenue | ![]() |
![]() | |
![]() | |
Owners |
|
Number of employees | 5,081 (March 2024) [2] |
Website |
www |
Indegene Limited is an Indian company that provides research and commercialization services to biopharmaceutical and healthcare enterprises. [4] [5] [6] Based in Bangalore, the company specializes in pharmaceutical marketing, clinical trials, pharmacovigilance, medical and regulatory affairs, and health informatics. [7] [8]
Indegene was founded in 1998 by Dr. Rajesh Nair, Manish Gupta, Gaurav Kapoor, Dr.Sanjay Parikh and Anand Kiran. [9] Indegene's first acquisition was Medsn, a company that provided medical education. Medsn continued to operate under the same name in the United States. [10] In 2008, Medsn officially became known as Indegene Pharmaceutical Solutions in the United States. In 2006, Indegene acquired MedCases, a continuing medical education company based in the United States. [6] [11]
In 2009, Indegene signed a master service agreement with six pharmaceutical companies. [5] [12] The following year, Indegene acquired Canada-based Aptilon, a multichannel marketing firm, for $4 million. [13] The company subsequently acquired Atlanta-based Total Therapeutic Management in 2014. [14]
In September 2019, Indegene acquired London-based consulting company, DT Associates, for $10 million. [15]
In February 2021, the Carlyle Group and Brighton Park Capital invested $200 million in Indegene. [16] In August 2021, Indegene acquired Medical Marketing Economics (MME), an American market access and pricing strategy company, for $10 million. [17]
Indegene went public in May 2024 with an initial public offering, raising ₹1,842 crore (US$220 million). It listed on the BSE and the NSE. [18]
Indegene has offices in India, the United States, the European Union, and Asia-Pacific. [19] [11]
In 2011 and 2012, The Economic Times named Indegene one of the best companies to work for in the Professional Services industry. [20]
![]() | This lead contains content that is written like
an advertisement. (August 2021) |
![]() | |
Formerly | Indegene Lifesystems Private Limited (1998–2016) Indegene Private Limited (2016–2022) |
---|---|
Company type | Public |
Industry | |
Founded | 1998 |
Founders | Rajesh Nair Manish Gupta Sanjay Parikh Anand Kiran Gaurav Kapoor |
Headquarters | , India |
Area served | Worldwide |
Key people | Manish Gupta (CEO) [1] |
Revenue | ![]() |
![]() | |
![]() | |
Owners |
|
Number of employees | 5,081 (March 2024) [2] |
Website |
www |
Indegene Limited is an Indian company that provides research and commercialization services to biopharmaceutical and healthcare enterprises. [4] [5] [6] Based in Bangalore, the company specializes in pharmaceutical marketing, clinical trials, pharmacovigilance, medical and regulatory affairs, and health informatics. [7] [8]
Indegene was founded in 1998 by Dr. Rajesh Nair, Manish Gupta, Gaurav Kapoor, Dr.Sanjay Parikh and Anand Kiran. [9] Indegene's first acquisition was Medsn, a company that provided medical education. Medsn continued to operate under the same name in the United States. [10] In 2008, Medsn officially became known as Indegene Pharmaceutical Solutions in the United States. In 2006, Indegene acquired MedCases, a continuing medical education company based in the United States. [6] [11]
In 2009, Indegene signed a master service agreement with six pharmaceutical companies. [5] [12] The following year, Indegene acquired Canada-based Aptilon, a multichannel marketing firm, for $4 million. [13] The company subsequently acquired Atlanta-based Total Therapeutic Management in 2014. [14]
In September 2019, Indegene acquired London-based consulting company, DT Associates, for $10 million. [15]
In February 2021, the Carlyle Group and Brighton Park Capital invested $200 million in Indegene. [16] In August 2021, Indegene acquired Medical Marketing Economics (MME), an American market access and pricing strategy company, for $10 million. [17]
Indegene went public in May 2024 with an initial public offering, raising ₹1,842 crore (US$220 million). It listed on the BSE and the NSE. [18]
Indegene has offices in India, the United States, the European Union, and Asia-Pacific. [19] [11]
In 2011 and 2012, The Economic Times named Indegene one of the best companies to work for in the Professional Services industry. [20]